Phathom Pharmaceuticals (PHAT)Director bought ~$81K
Asit Parikh, Director at Phathom Pharmaceuticals, bought ~$81K of Phathom Pharmaceuticals shares.
- ~$81K
- Approx. value · 10K sh @ $8.12
- 76K
- Holds after · shares reported
- Traded
- Dec 13, 2024
- Filed
- Dec 16, 2024
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Dec 13, 2024 · this disclosureInsiderDirector purchased ~$81K of PHAT shares in the open market
What came next
- Dec 13, 2024InsiderDirector purchased ~$99K of PHAT shares in the open market
- Dec 19, 2024Insider · 2 peopleInsiders: 2 sales (~$19K)
- Jan 21, 2025Insider · 3 peopleInsiders: 3 sales (~$221K)
- Mar 13, 2025InsiderDirector purchased ~$44K of PHAT shares in the open market
- Apr 7, 2025InsiderCFO sold ~$17K of PHAT shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Phathom Pharmaceuticals
OQRO holds no insider, Congress, fund or contract record for Phathom Pharmaceuticals dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PHAT page.
Other recent filings by Asit Parikh, Director
- SEC Form 4 at Phathom Pharmaceuticals (PHAT)May 8, 2025
- SEC Form 4 at Phathom Pharmaceuticals (PHAT)May 8, 2025
- SEC Form 4 at Phathom Pharmaceuticals (PHAT)Mar 17, 2025
The full history of Asit Parikh, Director is on the profile page.
How this filing works
Other disclosures at Phathom Pharmaceuticals
- SEC Form 13F-HRMay 15, 2026
- SEC Form 13F-HRFeb 17, 2026
- SEC Form 13F-HROct 20, 2025
- SEC Form 4Sep 9, 2025
- SEC Form 13F-HRAug 14, 2025
- SEC Form 13F-HRAug 7, 2025
Everything OQRO holds on this company is on its PHAT page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data